Leading science, pioneering therapies

Neural stem cells and brain cancer group publications

2016

Okawa S, Gagrica S, Blin C, Ender C, Pollard SM, Krijgsveld J.  2016.  Proteome and Secretome Characterization of Glioblastoma-Derived Neural Stem Cells.Stem Cells.
Carén H, Beck S, Pollard SM.  2016.  Differentiation therapy for glioblastoma – too many obstacles?Molecular & Cellular Oncology. 3(2):e1124174.
Martella A, Pollard SM, Dai J, Cai Y.  2016.  Mammalian Synthetic Biology: Time for Big MACs.ACS Synth Biol.
Garros-Regulez L, Aldaz P, Arrizabalaga O, Moncho-Amor V, Carrasco-Garcia E, Manterola L, Moreno-Cugnon L, Barrena C, Villanua J, Ruiz I et al..  2016.  mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.Expert Opin Ther Targets. 20(4):393-405.
Pollard SM, M Marqués-Torrejón Á.  2016.  Give it a REST!Elife. 5

2015

Carén H, Stricker SH, Bulstrode H, Gagrica S, Johnstone E, Bartlett TE, Feber A, Wilson G, Teschendorff AE, Bertone P et al..  2015.  Glioblastoma Stem Cells Respond to Differentiation Cues but Fail to Undergo Commitment and Terminal Cell-Cycle Arrest.Stem Cell Reports.
Toledo CM, Ding Y, Hoellerbauer P, Davis RJ, Basom R, Girard EJ, Lee E, Corrin P, Hart T, Bolouri H et al..  2015.  Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells.Cell Rep.

2014

2013

Hubert CG, Bradley RK, Ding Y, Toledo CM, Herman J, Skutt-Kakaria K, Girard EJ, Davison J, Berndt J, Corrin P et al..  2013.  Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.Genes Dev. 27(9):1032-45.
Stricker SH, Feber A, Engström PG, Carén H, Kurian KM, Takashima Y, Watts C, Way M, Dirks P, Bertone P et al..  2013.  Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner.Genes Dev. 27(6):654-69.
Carén H, Pollard SM, Beck S.  2013.  The good, the bad and the ugly: epigenetic mechanisms in glioblastoma.Mol Aspects Med. 34(4):849-62.
Pollard SM.  2013.  In vitro expansion of fetal neural progenitors as adherent cell lines.Methods Mol Biol. 1059:13-24.
Sofueva S, Yaffe E, Chan W-C, Georgopoulou D, Rudan MVietri, Mira-Bontenbal H, Pollard SM, Schroth GP, Tanay A, Hadjur S.  2013.  Cohesin-mediated interactions organize chromosomal domain architecture.EMBO J. 32(24):3119-29.
Ding Y, Hubert CG, Herman J, Corrin P, Toledo CM, Skutt-Kakaria K, Vazquez J, Basom R, Zhang B, Risler JK et al..  2013.  Cancer-Specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cells.Cancer Discov. 3(2):198-211.
Danovi D, Folarin A, Gogolok S, Ender C, Elbatsh AMO, Engström PG, Stricker SH, Gagrica S, Georgian A, Yu D et al..  2013.  A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1.PLoS One. 8(10):e77053.

2012

Engström PG, Tommei D, Stricker SH, Ender C, Pollard SM, Bertone P.  2012.  Digital transcriptome profiling of normal and glioblastoma-derived neural stem cells identifies genes associated with patient survival.Genome Med. 4(10):76.
Danovi D, Folarin AA, Baranowski B, Pollard SM.  2012.  High content screening of defined chemical libraries using normal and glioma-derived neural stem cell lines.Methods Enzymol. 506:311-29.
Falk A, Koch P, Kesavan J, Takashima Y, Ladewig J, Alexander M, Wiskow O, Tailor J, Trotter M, Pollard SM et al..  2012.  Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons.PLoS One. 7(1):e29597.

2011

Gómez-López S, Wiskow O, Favaro R, Nicolis SK, Pollard SM, Smith A.  2011.  Sox2 and Pax6 maintain the proliferative and developmental potential of gliogenic neural stem cells In vitro.Glia. 59(11):1588-99.
Hook L, Vives J, Fulton N, Leveridge M, Lingard S, Bootman MD, Falk A, Pollard SM, Allsopp TE, Dalma-Weiszhausz D et al..  2011.  Non-immortalized human neural stem (NS) cells as a scalable platform for cellular assays.Neurochem Int. 59(3):432-44.

Pages